Clinical Interventions and Diagnostics Branch

The Clinical Interventions and Diagnostics Branch supports research on the prevention, treatment, and management of individuals with or at-risk for cognitive decline, Alzheimer's disease, and related dementias. The branch supports all stages of clinical development for pharmacologic and nonpharmacologic interventions and combination therapies, as well as research on methods development and training for innovative trial design. The branch also supports research on diagnostics aimed at the development and evaluation of reliable and valid multidimensional diagnostic procedures and instruments, including imaging, fluid and digital biomarkers, and clinical and neuropsychological instruments for diagnosis, progression, and response to treatment. A central goal of the branch is the maintenance and development of research infrastructure for clinical trials and biomarkers development, which includes the national network of Alzheimer’s Disease Research Centers.

Branch Chief

Laurie Ryan, Ph.D.
Email Laurie Ryan

Clinical Interventions

Laurie Ryan, Ph.D.
Program Officer
Email Laurie Ryan

Kristina McLinden, Ph.D.
Program Officer
Email Kristina McLinden

Alvin McKelvy, Ph.D.
Health Science Specialist
Email Alvin McKelvy

Akanni Clarke, Ph.D.
Health Science Specialist
Email Akanni Clarke

Biomarkers and Diagnostics

John K. Hsiao, M.D.
Program Officer
Email John K. Hsiao

Alzheimer’s Disease Research Centers

Cerise Elliott, Ph.D.
Program Officer
Email Cerise Elliott

Nina Silverberg, Ph.D.
Program Officer
Email Nina Silverberg

Grayson Donley, M.S.
Program Specialist
Email Grayson Donley

Training and Technology

Yuan Luo, Ph.D.
Program Officer
Email Yuan Luo

Recruitment and Retention

Cerise Elliott, Ph.D.
Program Officer
Email Cerise Elliott